Tokyo, Sept. 30 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059234) titled 'Single-center prospective observational study investigating the impact of beta1 adrenergic receptor and its auto-antibody on responsiveness of beta-blocker in heart failure therapy' on Sept. 29.
Study Type:
Observational
Primary Sponsor:
Institute - Hamamatsu University School of Medicine
Condition:
Condition - heart failure
Classification by malignancy - Others
Genomic information - YES
Objective:
Narrative objectives1 - To investigate the relationship between clinical efficacy and genetic polymorphisms of beta1 adrenergic receptor and its auto-antibody in heart failure with beta-blocker.
Basic objectives2 - Sa...